Xeris Biopharma Holdings XERS
NASDAQ XERS
$9.26 -0.30 (-3.14%)
As of: Oct 1, 2026 · 3:59 PM EDT

Xeris Biopharma Holdings (XERS) Other financing activities (2020 - 2026)

Updated

Xeris Biopharma Holdings (XERS) posted Other financing activities of $191,000 for Q2 2026, down 77.8% from $860,000 a year earlier and down 98.9% from the prior quarter.

Analysis

Xeris Biopharma Holdings (XERS) Other financing activities (2020 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Other financing activities at Xeris Biopharma Holdings was $19.23 million, up 111.1% year-over-year; for FY2025, it was $10.88 million, up 191.3% from FY2024.

  • Annual Other financing activities shows a five-year compound annual growth rate of 14.2% (FY2020 to FY2025).
  • In prior years, Xeris Biopharma Holdings' Other financing activities was $3.73 million in FY2024 (+215.1%), $1.19 million in FY2023 (-75.7%), $4.88 million in FY2022 (+813.1%) and $534,000 in FY2021 (-90.5%).
  • The Q2 2026 figure stands as the lowest quarterly Other financing activities since Q4 2024.
  • On a year-over-year basis, Other financing activities increased in five of the last seven quarters, with growth averaging 208.7%.
  • The strongest year-over-year quarter for Other financing activities in the past five years was Q4 2025, with growth of 827.7%; the weakest was Q2 2023, with a decline of 91.6%.
  • According to Business Quant data, Other financing activities for the three prior quarters was $17.02 million (Q1 2026), $1.54 million (Q4 2025) and $478,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Xeris Biopharma Holdings 1.66 Bn 1.22 Bn 79.59 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 191,000.00
Mar 31, 2026 17.02 Mn
Dec 31, 2025 1.54 Mn
Sep 30, 2025 478,000.00
Jun 30, 2025 860,000.00
Mar 31, 2025 8.00 Mn
Dec 31, 2024 166,000.00
Sep 30, 2024 83,000.00
Jun 30, 2024 51,000.00
Mar 31, 2024 3.43 Mn
Dec 31, 2023 225,000.00
Sep 30, 2023 72,000.00
Jun 30, 2023 25,000.00
Mar 31, 2023 863,000.00
Dec 31, 2022 60,000.00
Sep 30, 2022 159,000.00
Jun 30, 2022 297,000.00
Mar 31, 2022 4.36 Mn
Dec 31, 2021 169,000.00
Mar 31, 2021 365,000.00
API Access

Xeris Biopharma Holdings Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=XERS&period=max&api_key=YOUR_API_KEY